Monograph

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002287: How Should the World Pay for a COVID-19 Vaccine?

Adrian Towse

002255: The Evolution of US Policy Responses to the Opioid Epidemic

Richard G. Frank

002090: Can a Strong Economic Case Be Made for Investing in the NHS?

Peter Smith

001860: Ten Years of the NIHR: Achievements and Challenges for the Next Decade

Dame Sally C. Davies

001664: Cost-per-QALY in the US and Britain: Damned if You Do and Damned if You Don’t

Milton Weinstein

001571: Universal Health Coverage: The Holy Grail?

Anne Mills

000652: Pharmaceuticals in seven nations

Robert Chew;George Teeling Smith;Nick Wells

000647: Pharmaceuticals in Developing Countries 1981-82

Office of Health Economics

000646: Pharmaceuticals Among the Sunrise Industries

Nick Wells

000493: To Publish or Not: Experience and Evidence About Publishing Hospital Outcomes Data

Anne R. Mason;Andrew Street

000491: The Economics of Dental Care

Ray Robinson;Darshan Patel;Rowena Pennycate

000490: How Much Should We Spend on the NHS?

Nancy Devlin

000489: What Could be Nicer than NICE?

Alan Williams

000488: The Impact of Ageing on Health Care Expenditures: Impending Crisis, or Misguided Concern?

Meena Seshamani

000487: Activity Based Funding for Hospitals: English Policy, International Experience

Andrew Street

000486: To Heal and Harm: An Economic View of Drug Safety

Jonathan Silcock;Clive Pritchard

000485: Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments

Andrew Briggs

000483: Quality in Primary Care: Economic Approaches to Analysing Quality-Related Physician Behaviour

Michael Kuhn

000481: Institutions for Industrial Competitiveness in the International Pharmaceutical Industry

Jorge Mestre-Ferrandiz;Jon Sussex

000480: The Life Cycle of Pharmaceuticals: A Cross-National Perspective

Patricia Danzon

000479: Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty

Adrian Towse

000477: Interpreting and Addressing Inequalities in Health: From Black to Acheson to Blair to... ?

Robert Evans

000476: Influencing Prescribing in a Primary Care Led NHS

Anne R. Mason;Michael F. Drummond;Jonathan Cooke;Adrian Towse

000475: Health Economics: An Introduction to Economic Evaluation

Gisela Kobelt

000474: Disability Adjusted Life Years (DALYs) for Decision-Making?

Julia Fox-Rushby

000473: Cost-Effectiveness Thresholds: Economic and ethical issues

Clive Pritchard;Nancy Devlin;Adrian Towse

000472: Why Care About Health Inequality?

Adam Oliver

000471: The Links of Public Health and Economic Development

Jeffrey Sachs

000470: The Economics of the Private Finance Initiative in the NHS

Office of Health Economics

000469: Don’t Look Back? Voluntary and Charitable Finance of Hospitals

John Mohan;Martin Gorsky

000468: Consolidation and Competition in the Pharmaceutical Industry

Hannah Kettler

000467: Capturing the Unexpected Benefits of Medical Research

Clive Pritchard

000466: The Road to Sustainability in the UK and German Biotechnology Industries

Steven Casper;Hannah Kettler

000465: Surgical Research and Development in the NHS - Promotion, Management and Evaluation

Katharine Johnston

000464: Productivity Costs: Principles and Practice in Economic Evaluation

Mark Sculpher

000463: Primary Care and the NHS Reforms: A Manager’s View

Robert Royce

000462: Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison

Patricia Danzon

000461: Narrowing the Gap between provision and need for medicines in developing countries

Hannah Kettler

000460: Managing to do Better: General Practice in the 21st Century

Gordon Moore

000459: Improving Population Health in Industrialised Nations

Office of Health Economics

000458: Health Care without Frontiers?

Lyndsay Mountford

000457: Benchmarking and Incentives in the NHS

Carol Propper

000456: Updating the Cost of a New Chemical Entity

Hannah Kettler

000455: Trade Mark Legislation and the Pharmaceutical Industry

Shelley Lane;Jeremy Phillips

000453: Risk and Return in the Pharmaceutical Industry

Nick Marchant

000452: Risk Adjusting Health Care Resource Allocations

Adam Oliver

000450: Organisational Costs in the New NHS

Bronwyn Croxson

000448: Genomics, Healthcare and Public Policy

Paul Williams;Sarah Clow

000447: Doctors, Economics and Clinical Practice Guidelines: Can they be brought together?

David M. Eddy

000446: Disease Management, the NHS and the Pharmaceutical Industry

Anne R. Mason;Michael F. Drummond;Adrian Towse